Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers

Bibliographic Details
Main Author: Delello Di Filippo, Leonardo [UNESP]
Publication Date: 2021
Other Authors: Hofstätter Azambuja, Juliana, Paes Dutra, Jessyca Aparecida [UNESP], Tavares Luiz, Marcela, Lobato Duarte, Jonatas [UNESP], Nicoleti, Luiza Ribeiro [UNESP], Olalla Saad, Sara Teresinha, Chorilli, Marlus [UNESP]
Format: Article
Language: eng
Source: Repositório Institucional da UNESP
Download full: http://dx.doi.org/10.1016/j.ejpb.2021.08.011
http://hdl.handle.net/11449/233458
Summary: Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies.
id UNSP_98f5fe332dc4c487eefd5318bdd9cd88
oai_identifier_str oai:repositorio.unesp.br:11449/233458
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriersBrain cancerCancer therapyDrug resistanceFunctionalizationGlioblastomaNanotechnologyGlioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies.School of Pharmaceutical Sciences São Paulo State University (UNESP)Hematology and Transfusion Medicine Center University of Campinas (UNICAMP)School of Pharmaceutical Science of Ribeirão Preto University of São Paulo (USP)School of Pharmaceutical Sciences São Paulo State University (UNESP)Universidade Estadual Paulista (UNESP)Universidade Estadual de Campinas (UNICAMP)Universidade de São Paulo (USP)Delello Di Filippo, Leonardo [UNESP]Hofstätter Azambuja, JulianaPaes Dutra, Jessyca Aparecida [UNESP]Tavares Luiz, MarcelaLobato Duarte, Jonatas [UNESP]Nicoleti, Luiza Ribeiro [UNESP]Olalla Saad, Sara TeresinhaChorilli, Marlus [UNESP]2022-05-01T08:44:46Z2022-05-01T08:44:46Z2021-11-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article76-89http://dx.doi.org/10.1016/j.ejpb.2021.08.011European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89.1873-34410939-6411http://hdl.handle.net/11449/23345810.1016/j.ejpb.2021.08.0112-s2.0-85113951060Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengEuropean Journal of Pharmaceutics and Biopharmaceuticsinfo:eu-repo/semantics/openAccess2025-03-29T05:16:08Zoai:repositorio.unesp.br:11449/233458Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-03-29T05:16:08Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
title Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
spellingShingle Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
Delello Di Filippo, Leonardo [UNESP]
Brain cancer
Cancer therapy
Drug resistance
Functionalization
Glioblastoma
Nanotechnology
title_short Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
title_full Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
title_fullStr Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
title_full_unstemmed Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
title_sort Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers
author Delello Di Filippo, Leonardo [UNESP]
author_facet Delello Di Filippo, Leonardo [UNESP]
Hofstätter Azambuja, Juliana
Paes Dutra, Jessyca Aparecida [UNESP]
Tavares Luiz, Marcela
Lobato Duarte, Jonatas [UNESP]
Nicoleti, Luiza Ribeiro [UNESP]
Olalla Saad, Sara Teresinha
Chorilli, Marlus [UNESP]
author_role author
author2 Hofstätter Azambuja, Juliana
Paes Dutra, Jessyca Aparecida [UNESP]
Tavares Luiz, Marcela
Lobato Duarte, Jonatas [UNESP]
Nicoleti, Luiza Ribeiro [UNESP]
Olalla Saad, Sara Teresinha
Chorilli, Marlus [UNESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (UNESP)
Universidade Estadual de Campinas (UNICAMP)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Delello Di Filippo, Leonardo [UNESP]
Hofstätter Azambuja, Juliana
Paes Dutra, Jessyca Aparecida [UNESP]
Tavares Luiz, Marcela
Lobato Duarte, Jonatas [UNESP]
Nicoleti, Luiza Ribeiro [UNESP]
Olalla Saad, Sara Teresinha
Chorilli, Marlus [UNESP]
dc.subject.por.fl_str_mv Brain cancer
Cancer therapy
Drug resistance
Functionalization
Glioblastoma
Nanotechnology
topic Brain cancer
Cancer therapy
Drug resistance
Functionalization
Glioblastoma
Nanotechnology
description Glioblastoma multiforme (GBM) is the most common primary brain cancer. GBM has aggressive development, and the pharmacological treatment remains a challenge due to GBM anatomical characteristics’ (the blood–brain barrier and tumor microenvironment) and the increasing resistance to marketed drugs, such as temozolomide (TMZ), the first-line drug for GBM treatment. Due to physical–chemical properties such as short half-life time and the increasing resistance shown by GBM cells, high doses and repeated administrations are necessary, leading to significant adverse events. This review will discuss the main molecular mechanisms of TMZ resistance and the use of functionalized nanocarriers as an efficient and safe strategy for TMZ delivery. GBM-targeting nanocarriers are an important tool for the treatment of GBM, demonstrating to improve the biopharmaceutical properties of TMZ and repurpose its use in anti-GBM therapy. Technical aspects of nanocarriers will be discussed, and biological models highlighting the advantages and effects of functionalization strategies in TMZ anti-GBM activity. Finally, conclusions regarding the main findings will be made in the context of new perspectives for the treatment of GBM using TMZ as a chemotherapy agent, improving the sensibility and biological anti-tumor effect of TMZ through functionalization strategies.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-01
2022-05-01T08:44:46Z
2022-05-01T08:44:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.ejpb.2021.08.011
European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89.
1873-3441
0939-6411
http://hdl.handle.net/11449/233458
10.1016/j.ejpb.2021.08.011
2-s2.0-85113951060
url http://dx.doi.org/10.1016/j.ejpb.2021.08.011
http://hdl.handle.net/11449/233458
identifier_str_mv European Journal of Pharmaceutics and Biopharmaceutics, v. 168, p. 76-89.
1873-3441
0939-6411
10.1016/j.ejpb.2021.08.011
2-s2.0-85113951060
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv European Journal of Pharmaceutics and Biopharmaceutics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 76-89
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1834482500313808896